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Abstract
Purpose Although some studies suggest that art therapy
may be useful in the treatment of negative symptoms of
schizophrenia, a recent large trial of group art therapy
found no clinical advantage over standard care, but the
study population was heterogeneous and uptake of the
intervention was poor. This study aimed to investigate
whether art therapy was more effective for specific sub-
groups of patients.
Methods Secondary analysis of data from a randomised
controlled trial of group art therapy as an adjunctive
treatment for schizophrenia (n = 140) versus standard care
alone (n = 137). Positive and Negative Syndrome Scale
scores at 12 months were compared between trial arms.
Interaction between intervention effect and different sub-
groups, including those with more severe negative symp-
toms of schizophrenia, and those who expressed a
preference for art therapy prior to randomisation, was
tested using a linear mixed model.
Results The clinical effectiveness of group art therapy did
not significantly differ between participants with more or
less severe negative symptoms [interaction for difference
in PANSS = 1.7, 95 % CI (-8.6 to 12.1), P = 0.741], or
between those who did and did not express a preference for
art therapy [interaction = 3.9, 95 % CI (-6.7 to 14.5),
P = 0.473]. None of the other exploratory subgroups
suggested differences in intervention effect.
Conclusions There was no evidence of greater improve-
ment in clinical symptoms of schizophrenia for those with
more severe negative symptoms or those with a preference
for art therapy. Identification of patients with schizophrenia
who may benefit most from group art therapy remains
elusive.
Keywords Art therapy  Schizophrenia  Randomised
controlled trial  Effect modifier  Subgroup analysis
Background
Schizophrenia is a severe mental illness affecting up to one
in a hundred people at some point in their lives. As well as
positive symptoms, such as hallucinations and delusions,
many people also experience negative symptoms, such as
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apathy and reduced organisational skills that can greatly
impair their everyday functioning [1]. Art therapy, a form
of psychotherapy which uses the medium of art to facilitate
personal expression and understanding of emotions [2], has
been shown through one exploratory trial to be associated
with improvement of negative symptoms of schizophrenia
(3) and, along with other arts therapies, is included in [3]
the United Kingdom (UK) National Institute for Health and
Clinical Excellence (NICE) guidelines for the treatment of
schizophrenia [4]. However, a recent large pragmatic ran-
domised controlled trial, the ‘‘MATISSE’’ study (Multi-
centre study of Art Therapy In Schizophrenia; Systematic
Evaluation), found no evidence of a population-level effect
of group art therapy over treatment as usual in terms of
global functioning or symptoms of mental illness [5].
Nevertheless, results from a qualitative sub-study con-
ducted alongside the MATISSE trial suggested that some
patients reported benefits from the intervention, such as
improvement in self esteem and social confidence [6].
Identifying subgroups of patients who are most likely to
benefit from an intervention is obviously important when
resource constraints limit its provision. However, large
datasets are required to identify factors predictive of better
outcome (such as patient characteristics). The MATISSE
study included over 400 participants with a diagnosis of
schizophrenia, an adequate sample size to explore potential
predictors of difference in effectiveness. Based on previous
research, two factors appear to be of particular interest: the
severity of negative symptoms experienced [3, 4]; and
having a preference for art therapy. One possible expla-
nation for the lack of effectiveness reported in the
MATISSE trial was the low uptake of art therapy groups
[7]. The trial was pragmatic in nature and included a het-
erogeneous group of participants. Beyond a general will-
ingness to be randomised to one of the trial arms and
adhere to the allocated treatment, no specific account was
taken of participants’ interest in art therapy before
recruitment and randomisation. Participant preference for
the interventions offered in a randomised trial may influ-
ence recruitment, attrition and adherence [8, 9]. It follows
that those who are randomised to receive their treatment of
choice may derive greater benefits than those with little
interest in it, possibly through higher adherence to the
intervention. It is also possible that those who were more
comfortable talking about their feelings and more inter-
ested in creative arts may have derived more benefit from
the art therapy groups. Similarly, those who are generally
more adherent with their mental health treatment may have
been more likely to engage constructively with the inter-
vention. Finally, the participants recruited into the
MATISSE trial had a median duration of illness of
15 years and it may be that the intervention has greater
effectiveness at an earlier stage of the illness.
In this study, we sought to investigate the hypotheses
that the clinical effectiveness of group art therapy delivered
in the MATISSE trial was related to (a) the severity of
negative symptoms of schizophrenia and (b) having a
preference for the art therapy intervention. We also
explored other related participant characteristics for their
association with the effectiveness of the intervention:
gender, adherence with current treatment and support;
degree to which they felt comfortable talking about their
feelings; interest in creative arts; and length of contact with
mental health services.
Methods
This paper reports results of a secondary analysis of data
collected in the MATISSE randomised controlled trial
(ISRCTN46150447). The trial protocol and main results
are reported elsewhere [10, 11].
MATISSE trial overview
The objective of the MATISSE trial was to evaluate the
clinical and cost-effectiveness of interactive group art
therapy for patients with a diagnosis of schizophrenia.
After recruitment, participants were randomly allocated to
one of three arms: treatment as usual; treatment as usual
plus activity group; treatment as usual plus interactive
group art therapy. The activity group provided an ‘‘atten-
tion control’’ arm to allow for the effect of attending a
group activity and is not part of this secondary analysis.
Participants were interviewed at recruitment, 12 and
24 months using standardised measures to assess symp-
toms of schizophrenia, global functioning, satisfaction with
care, engagement with treatment and social functioning.
The trial found that the addition of art therapy to usual care
resulted in no clinical advantage over usual care alone or
usual care plus activity groups and was not more cost-
effective [5].
Settings and participants
Participants were recruited in 15 community based sec-
ondary mental health and social care services in four cen-
tres across UK (West London, North London, Avon and
Wiltshire, and Belfast). Inclusion criteria included being at
least 18 years old and having a clinical diagnosis of
schizophrenia confirmed by operationalised criteria using
case note review [12]. Those whose mental health prob-
lems meant they lacked capacity to be able to give
informed consent to participate were excluded, as were
those unable to speak sufficient English to complete
baseline assessment, and those currently receiving any
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form of arts therapy (art, drama, dance, music, body psy-
chotherapy). All participants had to be willing to take part
in art therapy or activity groups and all provided written
informed consent to participate in the trial.
Intervention
Those randomised to art therapy were offered weekly
sessions of 90 min for an average period of 12 months.
Group art therapy was conducted in keeping with the rec-
ommendations of the British Association of Art Therapists
[13] and reflected usual group art therapy delivered in the
UK National Health Service. All groups were facilitated by
art therapists registered with the Health Professions
Council with previous experience of working with people
with psychosis, and co-facilitated by another member of
staff. A range of art materials were available and partici-
pants were encouraged to use them to express themselves
freely and spontaneously. Art therapists generally adopted
a supportive approach, offering empathy and encourage-
ment; they rarely provided symbolic interpretations of
interpersonal process or images to participants. Within this
framework, therapists used a range of interventions thought
appropriate to each participant. All art therapists received
monthly supervision from a senior art therapist in each
centre. Senior members of the study team assessed the
degree to which art therapy was delivered in accordance
with the study protocol guidance by reviewing proforma
completed by the art therapists after each session.
Treatment as usual comprised access to standard care
from secondary mental health services, including care
coordination, pharmacotherapy, and referral to other ther-
apies as clinically indicated, with the exception of arts
therapies.
Measures
The Positive and Negative Syndrome Scale (PANSS) [14]
is a standardised measure of symptom severity for patients
with schizophrenia. It comprises 30 items completed
through a structured interview with the researcher. Each
item is scored from 1 (pathology absent) to 7 (extreme
pathology), and items are summed to give a total score
from 30 to 210. The scale can be divided into three sub-
scales: positive, negative and general symptoms of
schizophrenia.
The Morisky scale [15] is a four-item self-report scale
that assesses participants’ non-adherence to medication.
Items are rated from 0 to 4, with four indicating poorer
adherence.
The Engagement and Acceptance Scale (EAS) [16] is a
four-item scale completed by the participant’s care co-
ordinator that assesses the degree to which the participant
is engaged with mental health services. Each item is rated
from 0 to 4 with a total score from 0 to 16, with higher
scores reflecting greater engagement.
At baseline, participants were asked whether they had
a preference for any one arm of the study (treatment as
usual, activity group, art therapy group, or no prefer-
ence). They were advised that their answer would not
affect the outcome of randomisation. Two additional
questions were also asked at the baseline interview, each
rated from 1 to 5. The first assessed participants’ views
of creative activities (1—I like being creative and make
opportunities to do creative things in everyday life; 5—I
avoid doing creative things). The second assessed the
degree to which they felt at ease talking about thoughts
and feelings (1—I am very comfortable describing what
I think and feel; 5—I am unable to describe what I think
and feel).
Subgroups
Subgroups were defined a priori, according to clinical
relevance or to median values of assessment measures.
Two subgroups were defined to test our primary hypotheses
and the others were used to explore other possible
interactions.
In keeping with previous literature [17, 18], a score of
20 or more on the negative symptoms subscale of the
PANSS was used to define participants with a high severity
of negative symptoms. For our preference subgroup ana-
lysis, participants who expressed a preference for art
therapy at recruitment were compared to those who
reported a preference for other trial arms or no preference.
Other subgroups were defined as follows; those with less
than and more than 10 years contact with mental health
services; those with good adherence to medication (Mori-
sky scale score 0) and poor adherence (Morisky scale score
1–4); those with greater and poorer engagement with ser-
vices (above and below the Engagement and Acceptance
Scale median score of 12); those who liked creative
activities (score 1 or 2 on our scale) and those who did not
(score 3–5); those who were more at ease talking about
their feelings (score 1 on our scale) and those who were not
(score 2–5).
Statistical analysis
A detailed statistical analysis plan was developed before
data analysis commenced and is available online [19].
Participants were compared according to their allocation
arm, independently of their adherence with the interven-
tion (intention-to-treat). When comparing proportions,
Soc Psychiatry Psychiatr Epidemiol (2014) 49:1703–1710 1705
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Pearson’s Chi-squared and Fisher’s exact tests were used
as appropriate. The main analysis compared PANSS score
at 12 months using a mixed-effect linear model, adjusting
for baseline PANSS and recruitment site (random effect).
The analysis was first carried out stratifying by subgroup
of interest to estimate the intervention effect within each
subgroup, and reported graphically in a forest-type plot.
The moderative effects of the subgroups on the outcome
were then tested by including an interaction term (sub-
group by randomisation arm). A significant interaction
parameter indicates that the effect of the intervention is
not the same in each subgroup and that the subgroup is a
‘‘modification factor’’ for the effectiveness of the inter-
vention. For continuous variables, the presence of a linear
interaction (variable by randomisation arm) was also
tested. Time since diagnosis was also log-transformed to
test for a possible non-linear interaction. Regarding
missing data, subgroups were only defined based on
observed data. For the outcome (PANSS) at 12 months
and at baseline, if a majority of the syndromes had been
assessed and few (\10 %) were missing, they were
imputed by regression imputation. If more than 10 % of
items were missing, the total PANSS was considered as
missing. Attrition and reasons for missingness were
compared between arms.
All statistical tests are two-sided, and significance con-
sidered at the 5 % level. All differences between trial arms
are reported for art therapy compared to treatment as usual.
The statistical software Stata (version 12, for Windows)
was used for all analyses.
Results
Participants
A total of 649 patients from 15 participating sites were
assessed for eligibility and 417 were enrolled into the trial,
including 277 randomised to either treatment as usual
(n = 137) or art therapy (n = 140) (Fig. 1). A total of 45
randomised participants (16 %) could not be included in
the analysis for various reasons (see Fig. 1). The attrition
rates at 12 months and the reason for attrition did not
significantly differ by arm [v2(1) = 0.17, P = 0.68 and
Fisher’s exact P = 0.65, respectively]. Attrition rates var-
ied by study sites (Fisher’s exact P \ 0.001), but no other
baseline characteristics were significantly related to attri-
tion. The amount of missing data was low: nine partici-
pants (3.2 %) had some of their PANSS items at baseline
or follow-up imputed for the analysis.
Fig. 1 Study flow chart
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Participants had a median age of 41 years old, and
68 % were male. The median duration of illness was
15 years, 32 % had been admitted to an inpatient
psychiatric unit in the previous 12 months, and 95 %
were prescribed antipsychotic medication. Some par-
ticipants had previous experience of art therapy (29 %),
and 11 % had experienced another form of creative
therapy.
Table 1 Attendance and outcome by subgroup of participants
Subgroup Frequency
n (%)
Attendance C2
sessions n (%)a
P value
attendance
PANSS score at
12 months
Mean (SD)
Adjustedb
difference
(95 % CI)
P value
subgroup
interaction
P value
linear
interaction
TAU ART
Overall 232 (100) 67/116 (58) 70.9 (24.5) 72.7 (27.1) -0.3 (-5.4 to 4.8)
Primary subgroups
Negative symptoms
No (\20) 136 (59) 37/65 (57) 0.740 61.9 (19.7) 62.0 (17.3) -0.6 (-6.5 to 5.2) 0.741 0.437
Yes (C20) 95 (41) 30/50 (60) 85.2 (24.8) 87.0 (31.0) 0.5 (-8.4 to 9.4)
Baseline arm preference
Preference for ART 93 (43) 27/39 (69) 0.073 73.2 (25.8) 76.6 (30.6) 2.5 (-6.0 to 10.9) 0.473 –
Other 125 (57) 35/68 (51) 67.9 (23.1) 70.2 (25.1) -1.2 (-7.9 to 5.5)
Exploratory subgroups
Gender
Male 158 (68) 40/72 (56) 0.539 70.6 (22.5) 71.0 (25.2) -0.9 (-6.9 to 5.1) 0.686 –
Female 74 (32) 27/44 (61) 72.0 (30.1) 75.4 (30.1) 1.0 (-8.7 to 10.7)
Time since diagnosis
\10 years 46 (21) 16/23 (70) 0.234 75.8 (28.1) 74.1 (24.8) -2.5 (-14.6 to 9.5) 0.756 0.700
C10 years 172 (79) 48/86 (56) 70.6 (23.9) 72.2 (28.6) -0.8 (-6.6 to 5.1)
Adherence to medication
Good
(Morisky = 0)
114 (50) 34/60 (57) 0.780 68.3 (23.8) 71.9 (26.9) 0.3 (-7.0 to 7.6) 0.768 0.614
Poor (Morisky C 1) 113 (50) 32/54 (59) 73.5 (25.2) 72.4 (27.2) -1.4 (-8.8 to 6.0)
Engagement and acceptance
Poor (EAS \ 12) 82 (51) 22/41 (54) 0.927 80.7 (23.7) 83.5 (33.7) -3.0 (-12.5 to 6.4) 0.786 0.600
Good (EAS C 12) 78 (49) 20/38 (53) 69.6 (26.3) 68.6 (23.9) -0.9 (-10 to 8.2)
Creative activities
Enjoy more (\3) 153 (67) 45/71 (63) 0.250 68.1 (25.4) 69.4 (26.6) -0.6 (-6.8 to 5.7) 0.913 0.580
Enjoy less (C3) 74 (33) 22/42 (52) 77.5 (21.1) 77.6 (28.3) 0.2 (-9.2 to 9.6)
Talking about thoughts
Comfortable (\2) 82 (36) 16/34 (47) 0.098 71.7 (26.9) 68.2 (26.1) 0.9 (-7.3 to 9.1) 0.894 0.672
Uncomfortable (C2) 146 (64) 51/80 (64) 70.1 (22.9) 74.4 (27.7) 0.1 (-6.7 to 6.8)
ART art therapy arm, TAU treatment as usual arm, SD standard deviation, EAS Engagement and Acceptance Scale
a Intervention arm only. %, proportion of patients in this subgroup in the intervention arm who attended at least two sessions of art therapy
b Difference between trial arms, adjusted for baseline PANSS score and clustering by site
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Attendance
Overall, attendance to the art therapy sessions was poor,
with 39 % of those allocated not attending any sessions,
and a median number of 11 sessions attended for the
remainder over the 12 month intervention period (range
1–51).
The proportion of participants who attended at least two
sessions of art therapy is reported for each subgroup in
Table 1. There was a suggestion of higher attendance in
patients who had expressed a preference for art therapy
when they were recruited [69 vs. 51 %, v2(1) = 3.2,
P = 0.073], and for those who reported that they were
comfortable speaking about their thoughts and feelings [64
vs. 47 %, v2(1) = 2.7, P = 0.098].
Relationship between subgroups and effectiveness
of art therapy
The estimated effect of art therapy, according to the sub-
groups of interest, is reported in Table 1 and plotted in
Fig. 2. In the subgroup of participants with more severe
negative symptoms, the adjusted mean difference between
arms in PANSS at 12 months was of 0.5 points [95 %
confidence intervals (CI) (-8.4 to 9.4)]. The effect of the
intervention did not differ between patients with or without
severe negative symptoms [interaction = 1.7, 95 % CI
(-8.6 to 12.1), v2(1) = 0.11, P = 0.741]. Similarly, when
testing for the PANSS negative subscale score as a linear
modification factor, the interaction term was not significant
[interaction = 0.3, 95 % CI (-0.4 to 1.0), v2(1) = 0.60,
P = 0.437], which suggests that the effectiveness of the
intervention was not associated with the severity of nega-
tive symptoms as assessed at baseline.
In the subgroup of participants who expressed a pref-
erence for art therapy at recruitment, those in the inter-
vention arm had on average a 2.5 higher PANSS score at
12 months [95 % CI (-6.0 to 10.9)], and there was no
significant difference in effect between those with or
without a preference for art therapy [interaction = 3.9,
95 % CI (-6.7 to 14.5), v2(1) = 0.51, P = 0.473].
None of the other exploratory subgroups showed sig-
nificant differences in intervention effect [v2(1) range:
0.01–0.31, P range: 0.580–0.914] (Table 1).
Discussion
We found no difference in the clinical effectiveness of
group art therapy in participants with more severe negative
symptoms, or between those with and without a preference
for art therapy. We found no significant moderating effect
on art therapy effectiveness of the other participant char-
acteristics we explored.
In its 2009 guidelines on the management of schizo-
phrenia [4], NICE recommended offering arts therapies,
particularly to people with negative symptoms. This rec-
ommendation was based on the 2009 guidelines (reference:
NICE (2009)), which reviewed six randomised trials of arts
therapies. The trials were of varying quality, but generally
suggested that creative therapies were associated with
reduction of negative symptoms [4]. Most of these trials
investigated music therapy, but one exploratory trial of art
therapy also showed an effect on negative symptoms [3].
Negative symptoms of schizophrenia may be associated
with difficulty engaging in psychological therapies, and art
Overall
Negative symptoms
Arm preference
Gender
Time since diagnosis
Adherence to medication
Engagment and acceptance
Creative activities
Talking about thoughts
No (<20)
Yes (>=20)
Preference for ART
Other
Male
Female
<10 years
>=10 years
Good
Poor
Poor
Good
Enjoy more
Enjoy less
Comfortable
Uncomfortable
Favour ART            Favour TAU
-15 -10 -5 0 5 10 15
Difference in PANSS
Fig. 2 Forest plot of mean difference between arms in PANSS at
12 months, by subgroup of participants. Estimated mean difference
(and 95 % CI) in PANSS score at 12 months, adjusted for baseline
PANSS and site. The size of the square is proportional to the number
of observations. The solid vertical line represents zero difference, and
the dashed vertical line the overall mean difference. ART art therapy
arm, TAU treatment as usual arm
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therapy may therefore be a suitable non-verbal alternative
for such patients. In theory, it might be expected that
interventions based on non-verbal expression that include a
social interaction element, such as interactive group art
therapy, could impact positively on the negative symptoms
of schizophrenia such as poor social rapport and emotional
withdrawal. However, the main analysis of the MATISSE
randomised trial did not find any effect of art therapy on
negative symptoms at 12 and 24 months. The present
analysis has further corroborated this finding: art therapy
was not found to be more effective for those with more
severe negative symptoms. There are a number of reasons
why the findings from the MATISSE study may have dif-
fered from those reported by Richardson et al. Firstly
Richardson’s study was an exploratory trial with high
attrition and multiple outcomes. The difference observed
between groups in ratings of negative symptoms was
around statistical significance level and may have been
observed by chance alone. Secondly, the form of art ther-
apy delivered may have differed from that delivered in the
MATISSE study, although they were both based on similar
guidelines [13, 20, 21]. Finally, outcomes in the MATISSE
study were assessed longer after recruitment (12 months)
than in the Richardson et al. study (6 months) and thus, any
initial clinical gains noted by Richardson et al. may have
dissipated over time.
Our second hypothesis explored the possibility that art
therapy may be more effective in patients who expressed a
preference for the intervention and might therefore be more
likely to engage with it. MATISSE was a pragmatic trial,
and included participants who may not have been enthu-
siastic or knowledgeable about art therapy. Restricting the
analysis to those who expressed a preference for art therapy
potentially offers a better estimate of the efficacy of the
intervention in those willing to engage with it. We found
that participants who expressed a preference for art therapy
appeared to have a slightly higher attendance but this did
not result in greater benefit. This finding is consistent with
a systematic review of ‘‘preference trials’’ by King et al.
[22] which showed little difference in effectiveness
between those allocated to their arm of preference, and
those randomly allocated. It may also be explained by the
absence of any overall effect of art therapy in the main
MATISSE study even after controlling for adherence to the
intervention [5].
Eligibility criteria in the MATISSE study were broad. In
view of the small effect observed when group art therapy
was offered to all patients with a diagnosis of schizo-
phrenia, and the resources involved in delivering such an
intervention, it is important to identify patients who appear
the most likely to benefit from it [6]. Subgroup analysis can
also shed light on the therapeutic mechanisms of an
intervention and generate hypothesis on why it may or may
not have work. We therefore performed exploratory anal-
yses to investigate whether other participant characteristics
were associated with the effectiveness of the intervention.
However, we did not identify any subgroups of participants
for whom art therapy appeared more effective. These
findings concur with the main findings of the MATISSE
study.
The MATISSE study is the largest randomised evalua-
tion of art therapy for schizophrenia to date and provided
sufficient data to investigate potential heterogeneity of the
effect of art therapy between subgroups. The main pitfall of
subgroup analysis is the increased risk of chance findings
when multiple unjustified comparisons are performed [23,
24]. This risk was reduced by restricting the number of
subgroups, and making the distinction between our two
primary hypotheses and further exploratory subgroups.
Another risk of subgroup analysis is if researchers identify
significant effect modifiers ‘‘by chance’’ during exploration
of the data, and become more likely to publish this finding.
This is why it is essential for subgroup analyses to be
specified a priori and to report all analyses performed [23,
24]. Although this secondary analysis was not planned as
early as the trial design stage (and with knowledge of the
main trial result), the analysis plan and scale cut-offs were
agreed before any exploration of possible effect modifiers.
The analysis plan [19] was then made publicly available
before commencing the analysis, to provide transparency
and prevent selective reporting. However, as the trial was
not designed to test for interactions, these secondary
analyses may have been under powered, since such anal-
yses require larger sample sizes, and non-statistically sig-
nificant effects do not demonstrate the absence of
interactions. Nevertheless, the sample size is sufficient to
rule out any important differences between subgroups. The
general limitations of the MATISSE trial, as reported in
Crawford et al. [5], also apply to this analysis: the use of
‘closed’ art therapy groups set up specifically for the trial
could explain the low attendance, even in those who
expressed a preference for art therapy; the small size of the
groups, which may have limited social interactions
between participants; the intervention may have offered
benefits in the shorter term, or on other outcomes valued by
the patients not assessed in the study [6]. The exploratory
analyses performed have further limitations, for example
non-standardised single item Likert-type scale was used to
assess the degree to which participants felt comfortable
talking about their feelings and their interest in creative
arts. Also, although no interaction with time of illness was
seen overall, due to small numbers in this subgroup, it was
not possible to asses if those recently diagnosed (e.g.
within 6 months) could have shown greater benefits.
Soc Psychiatry Psychiatr Epidemiol (2014) 49:1703–1710 1709
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Conclusion
This study did not demonstrate greater clinical benefit from
group art therapy for people with more severe negative
symptoms of schizophrenia, or for those who expressed a
preference for it. In view of the potential benefits but
conflicting evidence, further studies of creative therapies
for the treatment of schizophrenia are indicated.
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